NCT04823234 (PINK-CO) is a clinical trial of Lung ultrasound in Pregnancy Complications, sponsored by Azienda Sanitaria-Universitaria Integrata di Udine.

Who is sponsoring NCT04823234?

NCT04823234 is sponsored by Azienda Sanitaria-Universitaria Integrata di Udine.

What drugs are being tested in NCT04823234?

Interventions in NCT04823234: Lung ultrasound.

What condition does NCT04823234 study?

NCT04823234 studies Pregnancy Complications, Covid19.

Is NCT04823234 still recruiting?

NCT04823234 is currently completed. Last updated 28 September 2021.

Last reviewed 2021-09-28 · How we verify

NCT04823234: PINK-CO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women

Completed Last updated 28 September 2021

What this trial tests

trial testing Lung ultrasound in Pregnancy Complications in 40 participants. Completed in 15 September 2021.

Timeline

10 March 2021

Primary endpoint
30 June 2021

15 September 2021

Quick facts

Lead sponsor	Azienda Sanitaria-Universitaria Integrata di Udine
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	10 March 2021
Primary completion	30 June 2021
Estimated completion	15 September 2021
Sites	1 location across Italy

Drugs / interventions tested

Lung ultrasound

Conditions studied

Pregnancy Complications — all drugs for Pregnancy Complications →
Covid19 — all drugs for Covid19 →

Sponsor

Azienda Sanitaria-Universitaria Integrata di Udine — full company profile →

Who can join

Adults 18 to 55, female only, with Pregnancy Complications or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SARS-CoV-2 impact on pregnant women is not well known yet. Some authors demonstrated that lung ultrasound can give similar results if compared to chest computed tomography and better results if compared to chest x-rays without radiations and limited risks for mother and fetus. The Lung Ultrasound Score (LUS) can be used to asses the entity and monitor the evolution of lung impairment. Some authors described an artifact, the "light beam", as a typical ultrasound sign in COVID-19 positive patients. With our study we hypothesize to understand the prevalence of this sign and other ultrasound signs in pregnant COVID-19 positive patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The "PINK-CO" Observational Study.
Vetrugno L, Sala A, Orso D, Meroi F, et al · · 2021 · cited 16× · PMID 35127744 · DOI 10.3389/fmed.2021.768261

Verify or expand the search:

Other trials of Lung ultrasound

Trials testing the same drug.

NCT07442669 — Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration · NA · not yet recruiting
NCT07261956 — Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia · NA · recruiting
NCT06984120 — Increased Extravascular Lung Water in Asymptomatic Open-water Swimmers · completed
NCT06965634 — Investigation of the Effectiveness of Lung Ultrasonography in Intraoperative Fluid Management · not yet recruiting
NCT06584474 — THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA · Phase 4 · completed

Other recruiting trials for Pregnancy Complications

Currently open trials in the same condition.

NCT06814509 — Delivering HOPE (Helping Women Optimize Prenatal Equity) · NA · recruiting
NCT06875947 — EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA · NA · active not recruiting
NCT06711627 — Food Provision in Prenatal Care · NA · recruiting
NCT06957769 — Biological Impacts of Rising Temperatures on Maternal, Fetal, and Newborn Health: A Cohort Study (BIRTH Cohort) · recruiting
NCT06779916 — Autophagy/Apoptosis Balance in Placental Vascular Pathologies · recruiting

Other Azienda Sanitaria-Universitaria Integrata di Udine trials

Trials by the same sponsor.

NCT06750003 — 4K Versus 3D Total Laparoscopic Bilateral Oophorectomy: Tools in Comparison · NA · not yet recruiting
NCT06443736 — TRESPASS Clinical Study · NA · recruiting
NCT06100926 — Effectiveness of Virtual Reality (VR) in Non-oncologic Chronic Musculoskeletal Pain · NA · enrolling by invitation
NCT05914454 — Efficacy and Safety of Anakinra in Acute Respiratory Distress Syndrome · Phase 2 · unknown
NCT05526573 — Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04823234 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Sanitaria-Universitaria Integrata di Udine
Last refreshed: 28 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04823234.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing